OSIsoft Announces Support for Microsoft Digital Pharma
OSIsoft, Inc., the global leader in Real-time Performance Management (RtPM) software for the process manufacturing industries, announced its support of Microsoft Digital Pharma, a vision and solutions framework, based on open standards, that will help improve productivity, integrate disparate data sources, and enable better collaboration across the pharmaceutical value chain.
OSIsoft’s flagship RtPM Platform, powered by the PI System, will be part of the Digital Pharma initiative in response to the growing demand for instant, critical and actionable operational performance metrics across pharmaceutical and biotechnology organizations. Customers will also benefit from RtPM’s greater return on existing and new investments and continuous process improvement.
Pharmaceutical and biotechnology organizations have long realized the need to adopt manufacturing innovations to raise their quality product standards, improve their compliance obligations and gain real-time insight into their batch processes to speed time-to-market. However, many have been slow to adopt new technologies due to the economic pressures and high costs of updating or configuring old systems while meeting stringent FDA regulations.
OSIsoft’s RtPM Platform leverages Microsoft(R) Windows Server(TM), the Microsoft Office System, and its Smart Client infrastructure to help improve life sciences organizations by providing operational insights to all employees, leading to better, faster, more relevant decisions and actions throughout the operations cycle. In addition, RtPM’s events-driven tools leverage Microsoft .NET technology and Information Worker (IW) platform in a Service Oriented Architecture (SOA) to deliver unified, role-based portal views of information across the enterprise. These proven capabilities enable outstanding quality and consistency, batch accuracy, regulatory compliance and cost control. Major global pharmaceutical and biotechnology manufacturers already rely on RtPM to improve the quality of their manufacturing operations and optimize existing IT investments.
“With RtPM, OSIsoft helps companies achieve speed-to-insight, one of the industry imperatives Digital Pharma’s vision and solutions framework seeks to address, as well as easily meet compliance standards,” said Steve Shihadeh, general manager, Microsoft Healthcare and Life Sciences. “We are pleased to align with strong partners like OSIsoft, who have developed valuable industry-specific solutions, and who really exemplify the Digital Pharma vision.”
The RtPM Platform provides drug manufacturers with an accurate, real-time view of the operations environment at any given point throughout the production cycle. Drug makers can quickly analyze performance of multiple manufacturing paths along with detailed individual equipment performance. In addition, the RtPM Platform is an invaluable resource for regulatory compliance, providing full audit trail capabilities; gathering real-time and historical data from diverse sources, including events, databases and enterprise systems.
Because the RtPM Platform is based on OSIsoft’s proven PI System information architecture, it is designed for high reliability and massive scalability — elements that are critical in today’s pharmaceutical environments. It is also designed for fast deployment and easy integration with any existing IT infrastructures. This allows life sciences organizations to leverage existing assets and systems for improved agility, productivity and profitability.
“Due to the increase in production errors and the FDA’s demonstrated support of PAT, the life sciences industry must adopt new manufacturing practices to raise quality standards and improve inefficiencies,” said Michael Saucier, vice president of marketing at OSIsoft. “We are delighted to be working with Microsoft on the Digital Pharma initiative to deliver proven, complimentary technologies that not only speed effective, critical decision making but offer a lower total cost of ownership to support industry-wide innovation and improvement.”
About Microsoft’s Digital Pharma
Microsoft’s Digital Pharma provides a practical vision and framework that enables pharmaceutical companies to drive innovation across the enterprise and address strategic value-chain capability requirements. Using proven Microsoft technology, Digital Pharma illustrates how drug manufacturers can achieve speed-to-insight and value-for-cost: two distinct industry imperatives that lead the way for business transformation. More information can be found at http://www.microsoft.com/lifesciences .
About OSIsoft
OSIsoft delivers performance management software to the world’s leading process manufacturing, life sciences, and utility companies — anywhere real-time operational metrics fuel performance. With more than 10,000 installations worldwide, OSIsoft’s real-time data platform crosses IT and process boundaries to incorporate and display operational information. Providing comprehensive visibility into operations, the OSIsoft platform unlocks the potential for timely analysis and the ability to make critical, informed and profitable decisions.
Founded in 1980, OSIsoft, Inc. is headquartered in San Leandro, Calif., with operations worldwide and is privately held.
